Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001801198-26-000014
Filing Date
2026-05-12
Accepted
2026-05-12 07:06:27
Documents
58
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 6-K legn-20260331.htm   iXBRL 6-K 524905
2 EX-99.1 a991earningsreleaseq12026.htm EX-99.1 145936
3 EX-99.4 q126pipeline.htm EX-99.4 3169
9 legendlogo.jpg GRAPHIC 6967
10 GRAPHIC q126pipeline001.jpg GRAPHIC 179786
  Complete submission text file 0001801198-26-000014.txt   3358209

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT legn-20260331.xsd EX-101.SCH 40386
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT legn-20260331_cal.xml EX-101.CAL 62757
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT legn-20260331_def.xml EX-101.DEF 91230
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT legn-20260331_lab.xml EX-101.LAB 312623
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT legn-20260331_pre.xml EX-101.PRE 215173
61 EXTRACTED XBRL INSTANCE DOCUMENT legn-20260331_htm.xml XML 336972
Mailing Address 2101 COTTONTAIL LANE SOMERSET NJ 08873
Business Address 2101 COTTONTAIL LANE SOMERSET NJ 08873 732-850-5598
Legend Biotech Corp (Filer) CIK: 0001801198 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39307 | Film No.: 26965837
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)